Riskpilot← Back to searchSign inGet full accessRETOUCH CLINIC ApS
APSActiveCVR 37369705Hovedvagtsgade 8Beauty care and other beauty treatment activities · NACE 9622Est. 201615 employeeswww.retouch.dk
Revenue 2024
DKK 9,2M
+14% vs 2023
EBITDA margin
29.1%
+48% vs 2023
Equity ratio
40.7%
Financial strength
Net profit 2024
DKK 847K
+42% vs 2023
| Revenue | DKK 9,2M | +14% |
| EBITDA | DKK 2,7M | +48% |
| Net profit | DKK 847K | +42% |
| Total assets | DKK 10,9M | +35% |
| Equity | DKK 4,4M | +24% |
| Employees | 15 | — |
Legal name
RETOUCH CLINIC ApS
CVR number
37369705
Legal form
Anpartsselskab
NACE code
9622 · Beauty care and other beauty treatment activities
Founded
12. januar 2016
Share capital
DKK 50.000
Employees
15 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den administrerende direktør i forening med et bestyrelsesmedlem, af to bestyrelsesmedlemmer i
forening eller af bestyrelsesformanden.
Company purpose
Selskabets formål er at drive skønhedsklinik, herunder udførelse af laser- og injektionsbehandlinger, kosmetiske behandlinger, samt anden efter direktionens skøn hermed beslægtet virksomhed.
Address
Hovedvagtsgade 8
Email
jakob@retouch.dk
Website
www.retouch.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 408 | 1.580 | 3.498 | 5.870 | 6.830 | 8.056 | 8.470 | 8.057 | 9.216 |
| Staff expenses | -585 | -1.386 | -2.351 | -3.976 | -3.874 | -5.326 | -6.326 | -6.193 | -6.215 |
| EBITDA | -177 | 193 | 1.147 | 1.894 | 2.956 | 2.731 | 2.143 | 1.809 | 2.679 |
| Depreciation & amort. | -33 | -42 | -63 | -157 | -198 | -417 | -621 | -818 | -1.240 |
| EBIT | -211 | 151 | 1.084 | 1.737 | 2.758 | 2.314 | 1.522 | 991 | 1.439 |
| Net financials | -33 | -18 | -15 | -18 | -2 | -162 | -70 | -180 | -309 |
| Profit before tax | -243 | 133 | 1.070 | 1.719 | 2.756 | 2.152 | 1.452 | 810 | 1.130 |
| Tax | -53 | 32 | 250 | 401 | 603 | 444 | 352 | 216 | 283 |
| Net profit | -190 | 101 | 819 | 1.318 | 2.153 | 1.708 | 1.100 | 595 | 847 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 974 | 960 | 2.421 | 3.512 | 5.376 | 6.853 | 8.357 | 8.084 | 10.914 |
| Equity | -140 | -39 | 780 | 1.598 | 2.763 | 3.521 | 3.871 | 3.595 | 4.442 |
| Long-term debt | 450 | 450 | 188 | 86 | 78 | 98 | 114 | 0 | 1.999 |
| Short-term debt | 665 | 549 | 1.385 | 1.767 | 2.433 | 3.175 | 4.281 | 4.347 | 4.264 |
| Total debt | 1.115 | 999 | 1.573 | 1.853 | 2.511 | 3.273 | 4.395 | 4.347 | 6.263 |
EBITDA margin
29.1%
This company
15.8%
Market median
+84% vs market
20162024
Equity ratio
40.7%
This company
38.2%
Market median
+7% vs market
20162024
Return on equity
19.1%
This company
18.4%
Market median
+4% vs market
20162024
Net profit margin
9.2%
This company
8.1%
Market median
+14% vs market
20162024
Asset turnover
0.84×
This company
1.12×
Market median
+25% vs market
20162024
Debt / equity
1.46×
This company
0.62×
Market median
-135% vs market
20162024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-12 – 2016-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
VV Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2023 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
MADS STORM HOLDING I ApS | Company | 100.0% | 100.0% | 2021 |
FREDERIKKE WÜRTZ HOLDING ApS. | Company | 25.0% | 25.0% | 2016 |
| Individual | 25.0% | 25.0% | 2021 | |
CATHRINE WÜRTZ HOLDING ApS. | Company | 25.0% | 25.0% | 2016 |
| Individual | 25.0% | 25.0% | 2016 | |
| Individual | 25.0% | 25.0% | 2016 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
STORM ØRNSKOV INVEST A/S
RETOUCH CLINIC ApS Board members of RETOUCH CLINIC ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Valentina Valeria Domenica Merolli | Chief Executive Officer | 0 companies |
| Jakob Storm Ørnskov | Chairman | 0 companies |
| Mads Christian Storm | Board of Directors | 0 companies |
| Lasse Aalund Ørnskov | Board of Directors | 0 companies |